Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Immunol. 2010 Apr;22(2):245-50. doi: 10.1016/j.coi.2010.01.011. Epub 2010 Feb 9.

Immunity to stemness genes in human cancer.

Author information

  • 1Section of Hematology, Yale University, New Haven, CT 06510, USA. madhav.dhodapkar@yale.edu

Abstract

A growing body of data points to not only intraclonal heterogeneity and hierarchy of growth potential, but also plasticity of cellular differentiation within human tumors. Recent studies have also identified surprising overlap between pathways that regulate pluripotency in embryonal stem (ES) cells and oncogenesis. While there is a long history of targeting embryonal tissues toward cancer vaccines, recent identification of crucial stemness pathways in ES cells as well as putative cancer stem cells (CSCs) provides novel opportunities for antigen-specific targeted therapy. Here we discuss recent insights into the capacity of the immune system to target these pathways. Immunologic targeting of pathways associated with stemness has implications for both immune regulation of tumor growth as well as regenerative therapies with embryonal stem cells.

Copyright 2010 Elsevier Ltd. All rights reserved.

PMID:
20144857
[PubMed - indexed for MEDLINE]
PMCID:
PMC2892711
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk